These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 4679965

  • 21. Autoimmune hepatitis.
    Yarze JC.
    N Engl J Med; 1996 Apr 04; 334(14):923-4. PubMed ID: 8596591
    [No Abstract] [Full Text] [Related]

  • 22. Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis.
    Maggiore G, Bernard O, Hadchouel M, Alagille D.
    J Pediatr Gastroenterol Nutr; 1985 Aug 04; 4(4):655-8. PubMed ID: 4032180
    [Abstract] [Full Text] [Related]

  • 23. Rituximab in autoimmune pancytopenia: a case report and review of literature.
    Reale LD, Besa EC.
    Ann Hematol; 2007 Dec 04; 86(12):913-6. PubMed ID: 17541587
    [No Abstract] [Full Text] [Related]

  • 24. [Drug therapy of chronic active hepatitis].
    Ritland S.
    Tidsskr Nor Laegeforen; 1980 May 20; 100(14):974-6. PubMed ID: 7404549
    [No Abstract] [Full Text] [Related]

  • 25. [Our experiences with the immunosuppressive treatment of chronic active hepatitis].
    Górski M, Jablonska-Kaszewska I, Bielawski W.
    Dtsch Z Verdau Stoffwechselkr; 1976 May 20; 36(3-4):129-30. PubMed ID: 1021377
    [No Abstract] [Full Text] [Related]

  • 26. [Chronic hepatitis. Treatment].
    Varela JI, Rull S.
    Rev Med Univ Navarra; 1979 Dec 20; 23(4):41-4. PubMed ID: 575936
    [No Abstract] [Full Text] [Related]

  • 27. [Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
    Lagrue G, Bariéty J.
    Munch Med Wochenschr; 1970 Mar 20; 112(12):515-22. PubMed ID: 5467836
    [No Abstract] [Full Text] [Related]

  • 28. [Long-term results of immunosuppressive treatment of chronic aggressive hepatitis (author's transl)].
    Gottesmann T, Moeschlin S.
    Dtsch Med Wochenschr; 1978 Dec 15; 103(50):1989-93. PubMed ID: 720235
    [Abstract] [Full Text] [Related]

  • 29. [Immunosuppressive treatment in immunopathologic disorders].
    Salmon J, Lambert PH.
    J Belge Rhumatol Med Phys; 1967 Dec 15; 22(4):267-75. PubMed ID: 4390266
    [No Abstract] [Full Text] [Related]

  • 30. [Immunosuppressive therapy in autoimmune diseases].
    Schwenke H, Helbig W, Müldner J.
    Dtsch Gesundheitsw; 1971 Mar 25; 26(13):573-9. PubMed ID: 5576681
    [No Abstract] [Full Text] [Related]

  • 31. [Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
    Schneider G, Schimmelpfennig W, Theuer D, Wagner K, Zimmermann HB, Nack P.
    Z Gesamte Inn Med; 1969 Apr 15; 24(8):Suppl:124-6. PubMed ID: 5802052
    [No Abstract] [Full Text] [Related]

  • 32. Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years.
    Petrányi G, Leövey A, Szegedi G, Kakuk G, Bobory J.
    Acta Med Acad Sci Hung; 1971 Apr 15; 28(1):97-106. PubMed ID: 5133501
    [No Abstract] [Full Text] [Related]

  • 33. Results of immunosuppressive treatment: Prognosis in chronic active hepatitis.
    Pelikán V, Seidlová V, Sánová J, Komenda S.
    Acta Hepatogastroenterol (Stuttg); 1975 Aug 15; 22(4):210-4. PubMed ID: 1179942
    [Abstract] [Full Text] [Related]

  • 34. [Diagnosis and therapy of autoimmune hepatitis].
    Heintges T, Mohr L, Niederau C, Strohmeyer G.
    Z Gastroenterol; 1995 Aug 15; 33(8):462-7. PubMed ID: 7483741
    [Abstract] [Full Text] [Related]

  • 35. [Use of immunosuppressive cytostatic agents in children's diseases in our experience].
    Szotowa W, Ludwiczak H, Oknińska A, Zeligowska J, Serejska E.
    Wiad Lek; 1969 Jan 15; 22(2):93-100. PubMed ID: 5780338
    [No Abstract] [Full Text] [Related]

  • 36. [Glucocorticoids and immunosuppressive agents in liver diseases].
    Arpa Gutierrez FJ, Silva Pozo J.
    Rev Esp Enferm Apar Dig; 1970 Dec 01; 32(7):763-82. PubMed ID: 4926636
    [No Abstract] [Full Text] [Related]

  • 37. [Immunosuppressive therapy of polymyositis].
    Gundlach HJ.
    Psychiatr Neurol Med Psychol Beih; 1975 Dec 01; 20-21():26-30. PubMed ID: 829632
    [Abstract] [Full Text] [Related]

  • 38. [Etiopathogenetic aspects and immunosuppressive treatment of active chronic hepatitis].
    Miglio F, Facchini A, Stefanini GF, Mariani E, Gasbarrini GB, Labò G.
    Recenti Prog Med; 1977 Apr 01; 62(4):471-88. PubMed ID: 577618
    [No Abstract] [Full Text] [Related]

  • 39. [Current therapeutic management of chronic hepatitis].
    Oancea R.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982 Apr 01; 34(4):289-302. PubMed ID: 6131511
    [No Abstract] [Full Text] [Related]

  • 40. Experience with the use of 6-mercaptopurine and "Imuran" in the treatment of progressive hepatitis (active chronic hepatitis).
    Arter WJ, Perkns KW, Blackburn CR.
    Australas Ann Med; 1966 Aug 01; 15(3):222-6. PubMed ID: 5989539
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.